αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse-Reference-Cited by-同舟云学术

αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse

Published:2007-01 Issue:1 Volume:170 Page:110-125
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Hahm Kyungmin,Lukashev Matvey E.,Luo Yi,Yang William J.,Dolinski Brian M.,Weinreb Paul H.,Simon Kenneth J.,Chun Wang Li,Leone Diane R.,Lobb Roy R.,McCrann Donald J.,Allaire Normand E.,Horan Gerald S.,Fogo Agnes,Kalluri Raghu,Shield Charles F.,Sheppard Dean,Gardner Humphrey A.,Violette Shelia M.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference52 articles.

1. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis;Okada;Curr Mol Med,2005

2. Functions of pulmonary epithelial integrins: from development to disease;Sheppard;Physiol Rev,2003

3. Progressive renal disease: fibroblasts, extracellular matrix, and integrins;Norman;Exp Nephrol,1999

4. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis;Border;Hypertension,1998

5. Transforming growth factor-beta and Smad signalling in kidney diseases;Wang;Nephrology,2005

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α_vβ₆ Integrin Inhibitors;Journal of Medicinal Chemistry;2024-09-13

2. Utilizing integrin αvβ6-targeted PET imaging to longitudinally monitor radiation- induced pulmonary fibrosis in vivo;International Journal of Radiation Oncology*Biology*Physics;2024-09

3. A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast (PLN-74809) ameliorates organ injury and fibrogenesis in fibrotic kidney disease;European Journal of Pharmacology;2024-09

4. Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages;Cell Death & Disease;2024-06-06

5. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China;BMJ Open;2024-03